ADAM17 orchestrates Interleukin-6, TNFα and EGF-R signaling in inflammation and cancer
- 1 January 2022
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1869 (1) , 119141
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (125440785 – SFB 877, 80750187 – SFB 841, A14)
This publication has 121 references indexed in Scilit:
- iRhom2 Regulation of TACE Controls TNF-Mediated Protection Against Listeria and Responses to LPSScience, 2012
- Tumor Necrosis Factor Signaling Requires iRhom2 to Promote Trafficking and Activation of TACEScience, 2012
- Tissue inhibitors of metalloproteinasesGenome Biology, 2011
- Cross-domain inhibition of TACE ectodomainProceedings of the National Academy of Sciences, 2011
- Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17Nature Communications, 2011
- Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in miceJournal of Experimental Medicine, 2010
- The role of protease activity in ErbB biologyExperimental Cell Research, 2009
- Deficiency of TNFα Converting Enzyme (TACE/ADAM17) Causes a Lean, Hypermetabolic Phenotype in MiceEndocrinology, 2008
- An Essential Role for Ectodomain Shedding in Mammalian DevelopmentScience, 1998
- Protein kinase C activity is rate limiting for shedding of the interleukin-6 receptorBiochemical and Biophysical Research Communications, 1992